J&J pre­vails in schiz­o­phre­nia drug patent spat against Te­va

John­son & John­son beat back Te­va’s patent chal­lenge in a fed­er­al ap­peals court rul­ing that clos­es out a years­long fight over J&J’s an­tipsy­chot­ic med­ica­tion In­ve­ga …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER